San Francisco - Recent literature contains a number of reports with relevant information for enhancing the management of patients with cutaneous lupus erythematosus (CLE), Jeffrey P. Callen, M.D., said.
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Losing a Malpractice Case May Depend on Where You Live
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
The Role We Play in Addressing Racial Disparity in Dermatology
The Mainstream Patient: February 2